If you live In the United States where pharmaceutical companies advertise directly to consumers, in the last few years you’ve likely seen many ads for drugs whose unbranded names end in “mab.” Many of the advertised drugs are used to treat disorders such as rheumatoid arthritis, Crohn’s disease, psoriasis, asthma, Alzheimer’s disease, to mention a […]
Through partial funding by the Mesothelioma Applied Research Foundation, the National Comprehensive Cancer Network (NCCN) has published updated patient resources for malignant pleural mesothelioma. The resources include the NCCN Guidelines for Patients and NCCN Quick Guide sheet.
The NCCN Guidelines for Patients is based on the guidelines used globally in clinical practice to allow health care […]
by Jessica Blackford-Cleeton
A large number of warriors diagnosed with mesothelioma are over the age of 65, but there are several cases of diagnosis in early adulthood. Michelle Baetiong is one of those cases. A young warrior at the age of 22 and in college at the time of diagnosis, Michelle did not let mesothelioma stop […]
As of June 1, Dr. Kiran Turaga, a surgeon from the Medical College of Wisconsin, will be joining Dr. Hedy Kindler and the University of Chicago Medicine’s mesothelioma team.
Dr. Turaga began his career at the Medical College of Wisconsin in 2010. His interest has focused on peritoneal surface malignancies and regional therapies, which includes HIPEC.
The Meso Foundation recently hosted a Meet the Mesothelioma Experts session with Dr. Raphael Bueno, the chief of thoracic surgery at Brigham and Women’s Hospital in Boston, MA. He was interviewed by Mary Hesdorffer, the Meso Foundation’s executive director and nurse practitioner, and discussed his work and the future of his mesothelioma program.
When asked about […]